Skip to main content

MVT

ETF
Financials
Asset Management

Performance overview

MVT Price
Price Chart

Forward-looking statistics

Beta
0.15
Risk
10.35%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

Blackrock Munivest Fund II Inc is a closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.

Fund info

Blackrock Munivest Fund II Inc is a closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.

Investing methodUnknown
DiversifiedNo
Expense ratio—
Asset classUnknown

Top holdings

Other100.00%

Sector exposure

Other100.00%

Country exposure

Other100.00%

Company info

SectorFinancials
IndustryAsset Management
AUM$223.0M

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)$0.23
Dividend per share$0.65
Revenue per share$0.81
Avg trading volume (30 day)$615K
Avg trading volume (10 day)$639K
Put-call ratioN/A

Macro factor sensitivity

Growth-0.3
Credit+1.2
Liquidity-0.6
Inflation-0.3
Commodities-0.4
Interest Rates-1.2

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend day—

News

Wall Street Analysts See a 137.68% Upside in Immunovant (IMVT): Can the Stock Really Move This High?

The mean of analysts' price targets for Immunovant (IMVT) points to a 137.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research (July 16, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free